Previous Article | Next Article 
Journal of Virology, January 1999, p. 510-518, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Pathogenicity of Different Rabies Virus Variants
Inversely Correlates with Apoptosis and Rabies Virus Glycoprotein
Expression in Infected Primary Neuron Cultures
Kinjiro
Morimoto,1
D. Craig
Hooper,1
Sergei
Spitsin,2
Hilary
Koprowski,1 and
Bernhard
Dietzschold1,*
Center for Neurovirology, Department of
Microbiology and Immunology,1 and
Biotechnology Foundation Laboratories,2
Thomas Jefferson University, Philadelphia, Pennsylvania 19107-6799
Received 30 July 1998/Accepted 23 September 1998
 |
ABSTRACT |
The mouse-adapted rabies virus strain CVS-24 has stable variants,
CVS-B2c and CVS-N2c, which differ greatly in their pathogenicity for
normal adult mice and in their ability to infect nonneuronal cells. The
glycoprotein (G protein), which has previously been implicated in
rabies virus pathogenicity, shows substantial structural differences
between these variants. Although prior studies have identified
antigenic site III of the G protein as the major pathogenicity determinant, CVS-B2c and CVS-N2c do not vary at this site. The possibility that pathogenicity is inversely related to G protein expression levels is suggested by the finding that CVS-B2c, the less
pathogenic variant, expresses at least fourfold-higher levels of G
protein than CVS-N2c in infected neurons. Although there is some
difference between CVS-B2c- and CVS-N2c-infected neurons in G protein
mRNA expression levels, the differential expression of G protein
appears to be largely determined by posttranslational mechanisms that
affect G protein stability. Pulse-chase experiments indicated that the
G protein of CVS-B2c is degraded more slowly than that of CVS-N2c. The
accumulation of G protein correlated with the induction of programmed
cell death in CVS-B2c-infected neurons. The extent of apoptosis was
considerably lower in CVS-N2c-infected neurons, where G protein
expression was minimal. While nucleoprotein (N protein) expression
levels were similar in neurons infected with either variant, the
transport of N protein into neuronal processes was strongly inhibited
in CVS-B2c-infected cells. Thus, downregulation of G protein expression
in neuronal cells evidently contributes to rabies virus pathogenesis by
preventing apoptosis and the apparently associated failure of the
axonal transport of N protein.
 |
INTRODUCTION |
Accumulating evidence indicates that
the rabies virus glycoprotein (G protein) plays an essential role in
the pathogenicity of the virus. For example, the pathogenicity of the
tissue culture-adapted rabies virus strains ERA, HEP, and CVS has been
shown to correlate with the presence of a determinant located in
antigenic site III of the G protein (5, 18). Variants with
an Arg
Glu mutation at position 333 in site III of the G protein are
less pathogenic for immunocompetent adult mice than the wild-type
parental viruses (5, 18). The greatly reduced spread of
these antigenic site III mutants within the nervous system
(6) indicates that the appropriate G protein structure is
absolutely essential for the rapid axonal/transsynaptic spread of
rabies virus that leads to a lethal infection in adult animals. Based
on these findings, one might expect that site III mutations are the
single most important indicator of decreased pathogenicity. However, by
comparison with street rabies virus strains, rabies virus strains
adapted to nonneuronal cells in vitro, such as ERA, are already highly
attenuated with respect to pathogenicity for immunocompetent mammals
(15), despite having an unchanged antigenic site III. Thus,
the pathogenicity phenotype of a particular rabies virus strain is
determined not only by the determinants located in antigenic site III
of the G protein but also by other mechanisms which may or may not be related to the G protein. We recently found that the mouse
brain-adapted CVS-24 strain of rabies virus consists of two
phenotypically and genotypically distinct variants, CVS-B2c and CVS-N2c
(16). The amino acid sequences of the nucleoproteins (N
proteins) of both variants are identical, whereas the G proteins of
CVS-B2c and CVS-N2c differ in 10 amino acids outside antigenic site
III. While CVS-N2c is the dominant variant when CVS-24 is passaged in
mouse brain or neuroblastoma cells, passage in baby hamster kidney
(BHK-21) cells results in rapid selection of the CVS-B2c variant.
CVS-N2c replicates more readily in neuronal cells, whereas CVS-B2c
replicates better in nonneuronal cells. For normal adult mice, the
pathogenicity index (defined as the 50% lethal dose of a particular
virus stock preparation divided by the virus titer) of CVS-N2c is up to
50 times higher than that of CVS-B2c, depending on the route of
inoculation (16). The disparity in the pathogenicities of
these two variants must therefore depend either on differences outside
site III in the G protein or on other factors that determine the
capacity of the virus to invade, replicate, spread in neuronal tissue, and produce neurological disease.
In the present study, we used variants CVS-N2c and CVS-B2c as probes to
examine the mechanisms involved in rabies virus neuropathogenicity. We
demonstrated that G protein expression in infected primary neuron
cultures is different between the two variants and that the
downregulation of G protein expression in neurons is associated with
increased pathogenicity.
 |
MATERIALS AND METHODS |
Cells and viruses.
NA neuroblastoma cells of A/J mouse
origin were grown at 37°C in Eagle's minimum essential medium
supplemented with 10% heat-inactivated fetal bovine serum (FBS).
Primary neuron cultures were prepared from the hippocampi of prenatal
Swiss Webster mice (day 17 of gestation) as described previously
(2). Briefly, the isolated hippocampi were treated for 15 min at 37°C with 4 ml of 0.04% trypsin. After the addition of 5 ml
of Dulbecco's minimal essential medium (GIBCO BRL, Grand Island, N.Y.)
and 1 ml of FBS, cells were dispersed with a pipette with a
heat-polished tip and strained through a Falcon cell strainer. Cells
were layered on a 2-ml FBS cushion and centrifuged for 5 min at 1,000 rpm, and the pelleted cells were resuspended in Neurobasal medium
(GIBCO BRL) at a concentration of 5 × 105 cells/ml.
Cells (250 µl) were then plated on 18-mm round polylysine-coated coverslips and incubated in a 5% CO2 atmosphere for 1 h at 37°C, and the coverslips were placed on a layer of astrocytes
isolated from the brains of 2-day-old Swiss Webster mice and cultured
in 10-cm-diameter petri dishes as described previously (4).
The primary neurons grown on coverslips were more than 95% pure, as judged by size, morphology, and immunostaining for the panneuronal marker protein PGP9.5. After 2 days of culturing in Neurobasal medium,
neurons were infected with the CVS-24 variants CVS-N2c and CVS-B2c at a
multiplicity of infection (MOI) of 1, which resulted in infection of
more than 90% of the neurons within 24 h postinfection (p.i.), as
determined by staining with N protein-specific antibodies. Isolation
and characterization of these variants have been described elsewhere
(16). Because CVS-B2c replicates better in nonneuronal cells
than CVS-N2c and the latter does not cause plaques in nonneuronal cells, the titers of both viruses were determined with mouse
neuroblastoma cells and the fluorescent-focus assay.
Immunofluorescence analysis.
Neurons were fixed in 80%
acetone at 24, 48, and 72 h p.i. To detect N protein, fixed neuron
cultures were subjected to a direct fluorescence staining technique
with fluorescein isothiocyanate (FITC)-labeled anti-rabies virus N
protein-specific mouse monoclonal antibody (MAb) (Centocor, Malvern,
Pa.) as described previously (7). To detect G protein, fixed
neuron cultures were incubated with a monospecific rabbit antibody that
recognizes rabies virus G protein, and reactions were visualized with
FITC-labeled goat anti-rabbit immunoglobulin G (Sigma, St. Louis, Mo.).
Evans blue was used as a counterstain and appeared red under green fluorescence.
Immunoprecipitation.
Primary mouse neuron cultures were
infected with CVS-B2c or CVS-N2c at an MOI of 1. At 2, 24, or 48 h
p.i., the culture medium was replaced with methionine-free Neurobasal
medium containing 10 µCi of [35S]methionine/ml, and
incubation was continued for 24 h at 37°C. Cells were then lysed
with lysis buffer (10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% Triton
X-100, 0.5% sodium deoxycholate), protein content was determined, and
lysates were calibrated to the same protein concentration (400 µg/ml). Two micrograms of G protein-specific MAb 6-15c (kindly
provided by A. Osterhaus, Institute of Virology, Erasmus University
Hospital, Rotterdam, The Netherlands), 2 µg of N protein-specific MAb
377-7 (7), or 2 µg of actin-specific antibody was added to
400 µl of lysate, and the mixtures were incubated overnight at 4°C.
The resulting immune complexes were adsorbed to protein A-Sepharose
beads. After the beads were washed with lysis buffer containing 0.45%
sodium dodecyl sulfate (SDS), the precipitated proteins were
solubilized in a small volume of SDS sample buffer and subjected to
electrophoresis on an SDS-10% polyacrylamide gel. The gel was dried
and exposed to X-ray film, and protein bands were quantitated by
densitometry with the NIH 1.58 IMAGE program.
Pulse-chase analysis.
Primary neuron cultures were infected
with CVS-B2c or CVS-N2c at an MOI of 1. At 24 h p.i., the cells
were pulse-labeled for 1 h with 50 µCi of
[35S]methionine/ml. The medium was then replaced with
Neurobasal medium containing 2 mM unlabeled methionine. After 2, 6, and
12 h of chase with unlabeled methionine, neurons were lysed, and the lysates were subjected to immunoprecipitation with G or N protein-specific MAbs. Proteins were analyzed by SDS-polyacrylamide gel
electrophoresis as described above.
RNA extraction and Northern blot analysis.
Total RNA was
isolated from infected neuron cultures by the RNAzol B method (Biotex
Laboratories, Inc., Houston, Tex.). For Northern blot analysis,
aliquots containing 7.5 µg of RNA were electrophoresed on a 1%
agarose gel containing 2.2 M formaldehyde-0.1 M
morpholinepropanesulfonic acid (MOPS) buffer (pH 7.0), blotted on
Nytran nylon membranes, and hybridized with nick-translated [
-32P]dCTP-labeled cloned N or G protein cDNA as
described previously (16). Membranes were exposed to X-ray
film, and RNA bands were quantitated by densitometry with the NIH 1.58 IMAGE program.
Quantitative PCR.
Absolute and relative amounts of G and N
protein mRNAs produced in CVS-N2c- and CVS-B2c-infected neurons were
also assessed by the real-time quantitative PCR method (10).
Reverse transcription (RT) reactions were carried out with 2.5 µg of
total RNA and 1 µM reverse primer as described previously
(16). Serial dilutions of the RT products were then
subjected to PCR amplification with forward and reverse primers and a
dual-fluorescence dye-labeled probe (FAM-TAMRA). The nucleotide
sequences of the probes and primers were as follows: N-reverse primer,
5'-TCATCAGAGTTGACGGTTCCG-3'; G-reverse primer,
5'-TTGATTCATGTCGAGTCCGCT-3'; G3PDH-reverse primer: 5'-AGATGGTGATGGGCTTCCC-3'; N-forward primer,
5'-CAAGAATATGAGGCGGCTGAA-3'; G-forward primer,
5'-GATGACTCTGTGCTTGGGCA-3'; G3PDH-forward primer, 5'-GGCAAATTCAACGGCACAGT-3'; FAM-TAMRA dual-labeled N-probe,
5'-AAAGTCCGACGTGGCACTGGCAGA-3'; FAM-TAMRA dual-labeled
G-probe, 5'-AAAGAGGTCGTAGTGTGCCCCCCGA-3'; and FAM-TAMRA
dual-labeled G3PDH-probe, 5'-AGGCCGAGAATGGGAAGCTTGTCATC-3'.
The sequences of the N and G mRNA-specific probes and primers are
conserved between CVS-N2c and CVS-B2c. Amplification of glyceraldehyde-3-phosphate dehydrogenase (G3PDH) mRNA served as an
internal standard. Amplification was carried out for 40 cycles of
denaturation at 95°C for 15 s, annealing, and polymerization at
60°C for 1 min with a TaqMan EZ RT-PCR kit (The Perkin-Elmer Corp.).
PCR products were detected with the ABI Prism 7700 Sequence Detection
System. Standard curves were constructed by plotting CT values (points at which the amplification
blot crosses the threshold) against log nanogram amounts of total input
RNA. Based on the slope of the standard curves, the total amount of a
particular mRNA species was calculated as x = (b
y)/m, where x is the total amount of mRNA, b
is the intercept at log 0 ng of RNA, and m is the slope of
the standard curves. For y, a CT
value of 20 was arbitrarily chosen. To determine the normalized
amounts, the relative quantities (reciprocals of the total amounts) of
G and N protein mRNAs were divided by the relative quantity of G3PDH mRNA.
In situ terminal end labeling.
The terminal
deoxynucleotidyltransferase-mediated dUTP nick end-labeling (TUNEL)
method was used to detect DNA strand breaks indicative of apoptotic
cell death. At different times after infection, neurons grown on round
coverslips were treated with 4% paraformaldehyde in phosphate-buffered
saline (PBS) (pH 7.4) for 30 min at room temperature and washed with
PBS. A TUNEL assay with propidium iodide counterstain (red-orange) was
performed with an Apoptosis Detection System, Fluorescein, in
accordance with the manufacturer's protocol (Promega, Madison, Wis.).
Coverslips were mounted with the antifading mounting medium Vectashield
(Vector Laboratories) on microslides and examined on a Leitz Microlab
microscope under visible and UV illumination.
Annexin V assay.
Primary neuron cultures grown on round
glass coverslips were infected with the rabies virus variants and, at
24, 48, and 72 h p.i., washed with 0.1 M HEPES (pH 7.2) and
incubated for 10 min with FITC-labeled Annexin V and for 2 min with
propidium iodide (APOPTEST-FITC kit; NeXins Research, B. V.,
Hoeve, The Netherlands) in accordance with the manufacturer's
protocol. Cells were washed again with HEPES buffer and fixed with 4%
paraformaldehyde in PBS (pH 7.4) for 30 min at room temperature.
Coverslips were mounted with Vectashield on microslides and examined on
a fluorescence microscope with the standard setting for FITC
fluorescence detection.
 |
RESULTS |
Expression of the rabies virus N and G proteins in primary neuron
cultures.
Neurons were cultured for 2 days in Neurobasal medium
and infected with variant CVS-N2c or CVS-B2c virus at an MOI of 1, which results in optimal infection (more than 90% of the neurons at 24 h p.i.). Immunofluorescence analysis of G protein expression in
neurons at 24, 48, and 72 h p.i. revealed intense staining in cell
bodies and processes of neurons infected with the CVS-B2c variant (Fig.
1D to F). Much less staining was detected
in neurons infected with CVS-N2c (Fig. 1A to C). A similar analysis of
N protein expression revealed intense staining in all infected neurons, regardless of the virus variant used for infection (Fig.
2). However, CVS-N2c-infected neurons
(Fig. 2A to C) showed a constant fine granular staining pattern which
appeared to be more concentrated near the cell surface and which
extended into the neuronal processes, whereas CVS-B2-infected neurons
(Fig. 2D to F) showed large, discrete N protein-positive inclusion
bodies in the cell body cytoplasm and almost no N protein-specific
staining in neuronal processes for the first 48 h of culturing. At
72 h p.i., when CVS-B2c-infected neurons had begun to degenerate,
large amorphous masses stained positively for the N protein. These data
suggest that the N protein is transported into the processes of neurons
infected with CVS-N2c but is retained in the cell bodies of
CVS-B2c-infected neurons, with minimal peripheral translocation into
neuronal processes.

View larger version (136K):
[in this window]
[in a new window]
|
FIG. 1.
Immunofluorescence analysis of G protein expression in
primary neuron cultures infected with CVS-N2c (A, B, and C) or CVS-B2c
(D, E, and F) virus and examined at 24 (A and D), 48 (B and E), and 72 (C and F) h p.i. Hippocampal neurons isolated from prenatal mouse
brains (day 17 of gestation) were seeded on polylysine-coated glass
coverslips, which were then placed on top of a cell layer of mouse
astrocytes. After 2 days of culturing in Neurobasal medium, neurons
were infected at an MOI of 1 and subjected to immunofluorescence
analysis as described in Materials and Methods.
|
|

View larger version (110K):
[in this window]
[in a new window]
|
FIG. 2.
Immunofluorescence analysis of N protein expression in
primary neuron cultures infected with CVS-N2c (A, B, and C) or CVS-B2c
(D, E, and F) virus. Cells were stained at 24 (A and D), 48 (B and E),
and 72 (C and F) h p.i.
|
|
Immunoprecipitation analysis of lysates from primary mouse neuron
cultures infected with CVS-N2c or CVS-B2c (MOI, 1) indicated that,
while similar amounts of the N protein were produced in both cultures
between 2 and 24 h, 24 and 48 h, and 48 and 72 h p.i.,
significantly more G protein was produced in CVS-B2c-infected neurons
than in CVS-N2c-infected neurons throughout the period studied (Fig.
3A). The G/N protein ratio was
approximately fourfold higher in CVS-B2c-infected neurons than in their
CVS-N2c-infected counterparts (Fig. 3B). Similar results were obtained
with monoclonal and polyclonal antibodies against the N or G protein
(data not shown). These data suggest that G protein but not N protein
expression is differentially regulated in primary neuron cultures
infected with CVS-N2c or CVS-B2c. The differences in the levels of
expression of the G protein relative to those of the N protein between
CVS-B2c and CVS-N2c appeared to be dependent upon the nature of the
cells infected. In the experiments presented here, G/N protein ratios in neuroblastoma cells infected with CVS-B2c or CVS-N2c did not differ
significantly (Fig. 4).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoprecipitation analysis of the N and G proteins in
primary neurons infected with CVS-N2c or CVS-B2c virus (MOI, 1). At 2, 24, or 48 h p.i., the culture medium was replaced with
methionine-free Neurobasal medium containing 10 µCi of
[35S]methionine per ml, and incubation was continued for
24 h at 37°C. At 24 (lane 1), 48 (lane 2), or 72 (lane 3) h
p.i., cells were lysed and subjected to immunoprecipitation with G
protein-specific MAb (row 1), N protein-specific MAb (row 2), or
actin-specific antibody (row 3). Immune complexes were analyzed by
SDS-10% PAGE as described in Materials and Methods. The gel was dried
and exposed to X-ray film (A), and protein bands were quantitated by
densitometry with the NIH 1.58 IMAGE program (B). Cross-hatched bar,
CVS-N2c; hatched bar, CVS-B2c.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
Immunoprecipitation analysis of the N and G proteins in
NA neuroblastoma cells infected with CVS-N2c or CVS-B2c (MOI, 1). At
48 h p.i., the culture medium was replaced with methionine-free
RPMI 1640 medium containing 10 µCi of [35S]methionine
per ml, and incubation was continued for 24 h at 37°C. Cells
were lysed with lysis buffer and immunoprecipitated with G protein- or
N protein-specific MAb. The resulting immune complexes were analyzed by
SDS-10% PAGE as described in Materials and Methods. The gel was dried
and exposed to X-ray film (A), and protein bands were quantitated by
densitometry with the NIH 1.58 IMAGE program (B). Cross-hatched bar,
CVS-N2c; hatched bar, CVS-B2c.
|
|
Analysis of rabies virus mRNA expression in neuronal cells.
Northern blot analysis to determine the relative mRNA levels of the G
and N proteins in primary neuron cultures infected with CVS-N2c or
CVS-B2c indicated that slightly more N mRNA and G mRNA was produced in
CVS-B2c-infected neurons than in CVS-N2c-infected neurons at 48 h
p.i. (Fig. 5A), but little difference
between the two variants in their G/N mRNA ratios (0.13 for CVS-N2c and 0.22 for CVS-B2c) (Fig. 5B) was seen. Real-time quantitative PCR (10), also used to determine the G and N mRNA levels in
infected primary neuron cultures, revealed G/N mRNA ratios of 0.19 for CVS-N2c and 0.26 for CVS-B2c at 48 h p.i., as calculated from the
relative quantities of G and N mRNAs normalized to the relative quantity of G3PDH mRNA (Fig. 5C). Essentially identical ratios were
obtained from mRNA amounts normalized to the amount of 18S rRNA (data
not shown). Thus, both quantitative PCR analysis and Northern blot
analysis revealed that G/N mRNA ratios in CVS-B2c-infected neurons were
only slightly higher than those in CVS-N2c-infected neurons. This
finding contrasts with the protein expression data, which demonstrated
at least fourfold-higher G protein expression levels in
CVS-B2c-infected neurons than in CVS-N2c-infected neurons. Together,
these results suggest that differences in translational regulation or
posttranslational processing account, in large part, for the
differences in G protein expression levels.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 5.
Northern blot (A and B) and quantitative PCR (C)
analyses of N and G protein mRNAs in primary neuron cells infected with
CVS-N2c or CVS-B2c virus (MOI, 1). At 24 h p.i., total RNA was
extracted, electrophoresed in a 1% agarose gel containing
formaldehyde, transferred to nylon membranes, and hybridized with
specific 32P-labeled probes as described in Materials and
Methods. Membranes were exposed to X-ray film (A), and mRNA bands were
quantitated by densitometry with the NIH 1.58 IMAGE program (B). For
quantitative PCR analysis, RT reactions were carried out with 2.5 µg
of total RNA and 1 µM primer, and serial dilutions of the RT products
were subjected to PCR amplification as described in Material and
Methods. To obtain normalized amounts, the relative quantities of G and
N protein mRNAs were divided by the relative quantity of G3PDH mRNA
(C). From left to right, bars represent CVS-N2c N protein mRNA, CVS-N2c
G protein mRNA, CVS-B2c N protein mRNA, and CVS-B2c G protein mRNA.
|
|
Stability of rabies virus G and N proteins in cultured neurons
infected with CVS-B2c and CVS-N2c.
Pulse-chase analysis to
determine whether differences in G protein stability might underlie
differences in G protein expression in CVS-B2c-infected versus
CVS-N2c-infected neurons indicated rapid degradation of the G protein
from both variants (Fig. 6A) but a faster
decline of the G proteins from CVS-N2c than from CVS-B2c.
Interestingly, the rates of decay of both G proteins slowed at 2 h
after synthesis, with no further decay seen after 6 h (Fig. 6B).
However, the difference in the percentages of G protein that decayed in
CVS-B2c-infected versus CVS-N2c-infected neurons was sufficient to
result in higher levels of stable G protein in CVS-B2c-infected
neurons, consistent with the immunofluorescence and immunoprecipitation
data. The N protein was relatively stable after synthesis in both
infected cultures (Fig. 6A).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 6.
Pulse-chase analysis of the N and G proteins in primary
neurons infected with CVS-N2c or CVS-B2c virus (MOI, 1). At 24 h
p.i., neuron cultures were pulsed with 50 µCi of
[35S]methionine per ml for 1 h and then chased with
unlabeled methionine for 2, 6, and 12 h at 37°C. After the
chase, cells were lysed and immunoprecipitated with G protein- or N
protein-specific MAb. Immune complexes were analyzed by SDS-10% PAGE
as described in Materials and Methods. The gel was dried and exposed to
X-ray film (A), and G protein bands were quantitated by densitometry
with the NIH 1.58 IMAGE program (B). , CVS-N2c protein; , CVS-B2c
protein.
|
|
G protein expression, N protein transport, and the induction of
apoptosis in cultured neurons infected with rabies viruses CVS-B2c and
CVS-N2c.
Because the distributions of the N protein in neurons
infected with CVS-B2c and CVS-N2c differed (Fig. 2) despite the
identical amino acid sequences of this protein in the variants
(16), the differences in the distribution patterns were
probably not due to any effect of the N protein itself. Analysis of
cells stained with crystal violet revealed no major morphological
changes in CVS-N2c-infected neurons at 24 and 48 h p.i. (Fig.
7A and D, respectively), whereas neurons
infected with CVS-B2c showed shrinking of cell bodies as well as
thinning and degeneration of neuronal processes by 24 h p.i. (Fig.
7G) and even more extensive morphological changes by 48 h p.i.
(Fig. 7J). A TUNEL assay of infected neuron cultures revealed the
presence of only a few TUNEL signal-positive nuclei in CVS-N2c-infected
neurons at 24 and 48 h p.i. (Fig. 7B and E, respectively) but a
large number of TUNEL signal-positive nuclei in CVS-B2c-infected
neurons at 48 h p.i. (Fig. 7K). Furthermore, high-level Annexin V
binding in CVS-B2c-infected neurons was detected as early as 24 h
p.i. (Fig. 7I), whereas no significant Annexin V binding in
CVS-N2c-infected neurons was observed at either 24 or 48 h p.i.
Because DNA cleavage is likely to be a late event in the apoptotic
pathway, it is not surprising that TUNEL-positive cells appear late in
infection. However, Annexin V binding, which detects the exposure of
phosphatidylserine at the plasma membrane, is an early event in
apoptosis. Together, these results indicate that CVS-B2c causes
programmed cell death in parallel with high levels of G protein
expression within the first 24 h of infection, whereas
CVS-N2c-infected neurons express low levels of G protein in cultures
and evidently do not undergo extensive apoptosis during the first
48 h of infection.

View larger version (101K):
[in this window]
[in a new window]
|
FIG. 7.
Morphological changes and induction of apoptosis in
primary cultured neurons infected with CVS-N2c (A to F) or CVS-B2c (G
to L) virus. Neurons were stained with crystal violet (A, D, G, and J)
or stained for determination of apoptosis with the TUNEL assay (B, E,
H, and K) or FITC-labeled Annexin V (Ca2+-dependent
phospholipid binding protein) (C, F, I, and L) at 24 h p.i. (A to
C and G to I) and 48 h p.i. (D to F and J to L).
|
|
 |
DISCUSSION |
The induction of apoptosis in rabies virus-infected neurons has
been proposed as a potential pathogenic mechanism for rabies (13). If apoptosis is an important pathogenic mechanism in
rabies, the CVS-B2c variant, which is clearly more cytotoxic than
CVS-N2c for neurons in vitro, should be the more pathogenic of the
variants. However, our in vivo studies with normal adult mice have
shown that the pathogenicity index (50% lethal dose/virus titer) of CVS-N2c is up to 50-fold higher than that of CVS-B2c, depending on the
route of inoculation (16). This observation is not
completely unexpected, because apoptosis is an integral part of the
host defense response and should help limit the spread of infection. It
is possible that a rabies virus strain well adapted to its host can
avoid processes, such as apoptosis, that interfere with its survival.
There is evidence that apoptosis plays a role in the attenuation of
pathogenicity of other viruses, such as Sendai virus (12).
The fact that many pathogenic viruses contain antiapoptosis genes
(reviewed in reference 19) attests to the likelihood
that apoptosis contributes more to defense from infection than pathogenicity.
The availability of two closely related rabies virus variants, one that
rapidly induces apoptosis in neurons and one that does not, has allowed
us to delineate mechanisms which may be relevant to neuronal cell death
and the pathogenesis of rabies. Our data suggest a direct correlation
between G protein expression level and induction of apoptosis in
cultured neurons. Similar results have been obtained with the
relatively apathogenic ERA rabies virus strain and a more virulent CVS
rabies virus strain for G protein expression and the induction of
apoptosis in Jurkat T cells (20). Presumably, apoptosis
results in a limited infection in vivo, particularly if infection is in
the periphery, where the released G protein can stimulate a protective
immune response. The fact that stereotactic intracerebral injection or
intranasal administration of avirulent rabies virus strains can cause
either lethal or transient disease while intramuscular infection does not (5, 11, 24) tends to support the concept that apoptosis of peripheral neurons infected with rabies virus may prevent the spread
of the virus to the brain and, perhaps, may promote more rapid
induction of immunity. CVS-N2c-infected neurons, despite producing N
protein in amounts comparable to those produced by CVS-B2c-infected
neurons, produce at least fourfold less G protein. This differential
regulation of G protein expression appears to be only partially the
result of variations in rates of transcription or stability of the G
protein mRNAs, since Northern blot and quantitative PCR analyses
indicated only slight differences between CVS-N2c and CVS-B2c in the
levels of expression of their N and G protein mRNAs in primary neuron
cultures. It is noteworthy in this regard that the 3' and 5'
untranslated regions of the G protein mRNA are identical in CVS-N2c and
CVS-B2c (data not shown) and that no AU-rich elements, which are the
most common RNA-destabilizing elements (23), were identified
in these regions. Analysis of G protein mRNA decay in transiently
transfected cells might provide more conclusive evidence for possible
differences in G protein mRNA turnover between these two variants, but
DNA transfection experiments with cultured primary neurons, the only
relevant cells for such studies, are not possible, probably because of
the extreme vulnerability of these cells to in vitro manipulations.
Pulse-chase experiments showed that the higher G protein levels in
CVS-B2c-infected neurons were largely the result of the lower rate of
degradation of the CVS-B2c G protein than of the CVS-N2c G protein.
Structural motifs, such as destabilizing N-terminal residues or PEST
domains found in proteins that are subject to rapid degradation
(1, 22), are not present in the G protein of CVS-N2c or
CVS-B2c. However, since the differences between these rabies virus
variants in G protein expression levels are largely restricted to
neuronal cells, it is likely that a neuron-specific proteolytic pathway
is utilized to regulate the expression of rabies virus G proteins. In
this context, it has been shown that proteasomal proteolysis plays an
important role in neural regulation (8). For example,
degradation of the regulatory subunits of cyclic AMP-dependent protein
kinases has been identified as a molecular mechanism underlying
long-term synaptic plasticity (9). It is conceivable that
rabies virus G proteins differ in their affinity for chaperones that
target degradation, translocation, or posttranslational modification
pathways that lead to differences in G protein longevity.
Our data suggest an association among three events that may be related
to the pathogenesis of rabies. In neurons infected with the highly
cytopathic CVS-B2c variant, high levels of G protein are expressed on
the cell surface, transport of N protein into cell processes is
inhibited, and cells rapidly undergo apoptosis. On the other hand,
neurons infected with the CVS-N2c variant do not express high levels of
G protein, allow efficient transport of N protein into neuronal
processes, and do not exhibit signs of apoptosis, at least in the first
48 h after infection. Although further studies are required to
determine the relationship between the induction of apoptosis and G
protein expression, we speculate that the failure of N protein
transport is linked to the apoptotic pathway, perhaps through the
depolymerization of actin filaments (14), which are
essential for the intracellular transport of the N proteins of several
RNA viruses, including rabies virus (3, 17).
A number of studies have concluded that the rabies virus G protein is a
major determinant of rabies virus pathogenicity (5, 18).
Mutations in antigenic site III of the G protein reduce the spread of
the virus (6), reduce receptor binding activity (21), and abolish its pathogenicity for adult mice (5,
18). In the present study, we identified a mechanism, evidently
involving apoptosis, that regulates the pathogenicity of rabies virus
independently of receptor binding. The fact that the induction of
apoptosis in neurons appears to correlate with the expression of high
levels of the G protein may indicate that there is a cause and effect relationship between these two events. However, this interpretation must be viewed with caution. We found that the CVS variants studied here have identical N proteins, 1 amino acid difference in the NS
protein, 4 amino acid differences in the M protein, and 10 in the G
protein (16; data not shown). Therefore, we cannot exclude a possible contribution of the NS, M, or L protein to the
induction of apoptosis and the related pathogenic phenotype. The
involvement of these proteins in rabies pathogenesis can only be
resolved through the use of reverse genetics technology. Nevertheless, preliminary results indicate that street rabies virus strains (dog- and
silver-haired bat-derived rabies virus strains), which are considerably
more pathogenic than tissue culture-adapted strains, express very
limited levels of the G protein in neuronal cells and do not induce apoptosis.
 |
ACKNOWLEDGMENTS |
We thank Heather Carbaugh for excellent help in the preparation
of neuron cultures. We also thank R. Pereira for invaluable assistance
in quantitative PCR analysis.
This work was supported by Public Health Service grant AI 09706.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Center for
Neurovirology, Department of Microbiology and Immunology, Thomas
Jefferson University, 1020 Locust St., Philadelphia, PA 19107-6799. Phone: (215) 503-4692. Fax: (215) 923-7145. E-mail:
bdietzschold{at}reddi1.uns.tju.edu.
 |
REFERENCES |
| 1.
|
Bergold, P.,
S. A. Beushausen,
T. C. Sacktor,
S. Cheley,
H. Bayley, and J. H. Schwartz.
1992.
A regulatory subunit of the cAMP-dependent protein kinase down-regulated in aplysia sensory neurons during long-term sensitization.
Neuron
8:387-392[Medline].
|
| 2.
|
Brewer, G. J.,
J. R. Torricelli,
E. K. Evege, and P. J. Price.
1993.
Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination.
J. Neurosci. Res.
35:567-576[Medline].
|
| 3.
|
Ceccaldi, P.-E.,
F. Valtorta,
S. Braud,
R. Hellio, and H. Tsiang.
1997.
Alteration of the actin-based cytoskeleton by rabies virus.
J. Gen. Virol.
78:2831-2835[Abstract].
|
| 4.
|
Cole, R., and J. de Vellis.
1997.
Astrocyte and oligodendrocyte cultures, p. 117-130.
In
S. Fedoroff, and A. Richardson (ed.), Protocols for neural cell cultures. Humana Press, Totowa, N.J.
|
| 5.
|
Dietzschold, B.,
W. H. Wunner,
T. J. Wiktor,
A. D. Lopes,
M. Lafon,
C. L. Smith, and H. Koprowski.
1983.
Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.
Proc. Natl. Acad. Sci. USA
80:70-74[Abstract/Free Full Text].
|
| 6.
|
Dietzschold, B.,
T. J. Wiktor,
J. Q. Trojanowski,
R. I. Macfarlan,
W. H. Wunner,
M. J. Torres-Anjel, and H. Koprowski.
1985.
Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro.
J. Virol.
56:12-18[Abstract/Free Full Text].
|
| 7.
|
Dietzschold, B.,
C. E. Rupprecht,
M. Tollis,
J. Mattei,
T. J. Wiktor, and H. Koprowski.
1988.
Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies.
Rev. Infect. Dis.
10:5785-5798.
|
| 8.
|
Gastel, J.,
P. H. Roseboom,
P. A. Rinaldi,
J. L. Weller, and D. C. Klein.
1998.
Melatonin production: proteasomal proteolysis in serotonin N-acetyltransferase regulation.
Science
279:358-360[Abstract/Free Full Text].
|
| 9.
|
Hegde, A. N.,
K. Inokuchi,
W. Pei,
A. Casadio,
M. Ghirardi,
D. G. Chain,
K. C. Martin,
E. R. Kandel, and J. H. Schwartz.
1997.
Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in aplysia.
Cell
89:115-126[Medline].
|
| 10.
|
Heid, C. A.,
J. Stevens,
K. J. Livak, and P. M. Williams.
1996.
Real time quantitative PCR.
Genome Res.
6:986-994[Abstract/Free Full Text].
|
| 11.
|
Hooper, D. C.,
K. Morimoto,
M. Bette,
M. Weihe,
H. Koprowski, and B. Dietzschold.
1998.
Collaboration of antibody and inflammation in the clearance of rabies virus from the central nervous system.
J. Virol.
72:3711-3719[Abstract/Free Full Text].
|
| 12.
|
Itoh, M.,
H. Hotta, and M. Homma.
1998.
Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity.
J. Virol.
72:2927-2934[Abstract/Free Full Text].
|
| 13.
|
Jackson, A. C., and J. P. Rossiter.
1997.
Apoptosis plays an important role in experimental rabies virus infection.
J. Virol.
71:5603-5607[Abstract].
|
| 14.
|
Kothakota, S.,
T. Azuma,
C. Reinhard,
A. Klippel,
J. Tang,
K. Chu,
T. J. McGarry,
M. W. Kirschner,
K. Koths,
D. J. Kwiatkowski, and L. T. Williams.
1997.
Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis.
Science
278:294-297[Abstract/Free Full Text].
|
| 15.
|
Lawson, K. F.,
R. Hertler,
K. M. Charlton,
J. B. Campbell, and A. J. Rhodes.
1989.
Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
Can. J. Vet. Res.
53:438-444[Medline].
|
| 16.
|
Morimoto, K.,
D. C. Hooper,
H. Carbaugh,
Z. F. Fu,
H. Koprowski, and B. Dietzschold.
1998.
Rabies virus quasispecies: implications for pathogenesis.
Proc. Natl. Acad. Sci. USA
95:3152-3156[Abstract/Free Full Text].
|
| 17.
|
Ravkov, E. V.,
S. T. Nichol,
C. J. Peters, and R. W. Compans.
1998.
Role of actin microfilaments in Black Creek Canal virus morphogenesis.
J. Virol.
72:2865-2870[Abstract/Free Full Text].
|
| 18.
|
Seif, I.,
P. Coulon,
P. E. Rollin, and A. Flamand.
1985.
Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein.
J. Virol.
53:926-934[Abstract/Free Full Text].
|
| 19.
|
Teodoro, J. G., and P. E. Branton.
1997.
Regulation of apoptosis by viral gene products.
J. Virol.
71:1739-1746[Medline].
|
| 20.
|
Thoulouze, M.-I.,
M. Lafage,
J. A. Montano-Hirose, and M. Lafon.
1997.
Rabies virus infects mouse and human lymphocytes and induces apoptosis.
J. Virol.
71:7372-7380[Abstract].
|
| 21.
|
Tuffereau, C.,
J. Benejean,
A.-M. R. Alfonso,
A. Flammand, and M. C. Fishman.
1998.
Neuronal cell surface molecules mediate specific binding to rabies virus glycoprotein expressed by a recombinant baculovirus on the surfaces of lepidopteran cells.
J. Virol.
72:1085-1091[Abstract/Free Full Text].
|
| 22.
|
Varshavsky, A.
1992.
The N-end rule.
Cell
69:725-735[Medline].
|
| 23.
|
Xu, N.,
C.-Y. Chen, and A.-B. Shyu.
1997.
Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay.
Mol. Cell. Biol.
17:4611-4621[Abstract].
|
| 24.
|
Yang, C., and A. C. Jackson.
1992.
Basis of neurovirulence of avirulent rabies virus variant Av01 with stereotaxic brain inoculation in mice.
J. Gen. Virol.
73:895-900[Abstract/Free Full Text].
|
Journal of Virology, January 1999, p. 510-518, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gholami, A., Kassis, R., Real, E., Delmas, O., Guadagnini, S., Larrous, F., Obach, D., Prevost, M.-C., Jacob, Y., Bourhy, H.
(2008). Mitochondrial Dysfunction in Lyssavirus-Induced Apoptosis. J. Virol.
82: 4774-4784
[Abstract]
[Full Text]
-
Pulmanausahakul, R., Li, J., Schnell, M. J., Dietzschold, B.
(2008). The Glycoprotein and the Matrix Protein of Rabies Virus Affect Pathogenicity by Regulating Viral Replication and Facilitating Cell-to-Cell Spread. J. Virol.
82: 2330-2338
[Abstract]
[Full Text]
-
Scott, C. A., Rossiter, J. P., Andrew, R. D., Jackson, A. C.
(2008). Structural Abnormalities in Neurons Are Sufficient To Explain the Clinical Disease and Fatal Outcome of Experimental Rabies in Yellow Fluorescent Protein-Expressing Transgenic Mice. J. Virol.
82: 513-521
[Abstract]
[Full Text]
-
Faber, M., Faber, M.-L., Li, J., Preuss, M. A. R., Schnell, M. J., Dietzschold, B.
(2007). Dominance of a Nonpathogenic Glycoprotein Gene over a Pathogenic Glycoprotein Gene in Rabies Virus. J. Virol.
81: 7041-7047
[Abstract]
[Full Text]
-
Jackson, A. C., Scott, C. A., Owen, J., Weli, S. C., Rossiter, J. P.
(2007). Therapy with Minocycline Aggravates Experimental Rabies in Mice. J. Virol.
81: 6248-6253
[Abstract]
[Full Text]
-
Marston, D. A., McElhinney, L. M., Johnson, N., Muller, T., Conzelmann, K. K., Tordo, N., Fooks, A. R.
(2007). Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region. J. Gen. Virol.
88: 1302-1314
[Abstract]
[Full Text]
-
Faber, M., Faber, M.-L., Papaneri, A., Bette, M., Weihe, E., Dietzschold, B., Schnell, M. J.
(2005). A Single Amino Acid Change in Rabies Virus Glycoprotein Increases Virus Spread and Enhances Virus Pathogenicity. J. Virol.
79: 14141-14148
[Abstract]
[Full Text]
-
Prehaud, C., Megret, F., Lafage, M., Lafon, M.
(2005). Virus Infection Switches TLR-3-Positive Human Neurons To Become Strong Producers of Beta Interferon. J. Virol.
79: 12893-12904
[Abstract]
[Full Text]
-
Wang, Z. W., Sarmento, L., Wang, Y., Li, X.-q., Dhingra, V., Tseggai, T., Jiang, B., Fu, Z. F.
(2005). Attenuated Rabies Virus Activates, while Pathogenic Rabies Virus Evades, the Host Innate Immune Responses in the Central Nervous System. J. Virol.
79: 12554-12565
[Abstract]
[Full Text]
-
Faber, M., Pulmanausahakul, R., Nagao, K., Prosniak, M., Rice, A. B., Koprowski, H., Schnell, M. J., Dietzschold, B.
(2004). Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. USA
101: 16328-16332
[Abstract]
[Full Text]
-
Nakamichi, K., Inoue, S., Takasaki, T., Morimoto, K., Kurane, I.
(2004). Rabies Virus Stimulates Nitric Oxide Production and CXC Chemokine Ligand 10 Expression in Macrophages through Activation of Extracellular Signal-Regulated Kinases 1 and 2. J. Virol.
78: 9376-9388
[Abstract]
[Full Text]
-
Kassis, R., Larrous, F., Estaquier, J., Bourhy, H.
(2004). Lyssavirus Matrix Protein Induces Apoptosis by a TRAIL-Dependent Mechanism Involving Caspase-8 Activation. J. Virol.
78: 6543-6555
[Abstract]
[Full Text]
-
Xiang, Z., Li, Y., Gao, G., Wilson, J. M., Ertl, H. C. J.
(2003). Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice. J. Immunol.
171: 4287-4293
[Abstract]
[Full Text]
-
Prehaud, C., Lay, S., Dietzschold, B., Lafon, M.
(2003). Glycoprotein of Nonpathogenic Rabies Viruses Is a Key Determinant of Human Cell Apoptosis. J. Virol.
77: 10537-10547
[Abstract]
[Full Text]
-
McGettigan, J. P., Pomerantz, R. J., Siler, C. A., McKenna, P. M., Foley, H. D., Dietzschold, B., Schnell, M. J.
(2002). Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic. J. Virol.
77: 237-244
[Abstract]
[Full Text]
-
Faber, M., Pulmanausahakul, R., Hodawadekar, S. S., Spitsin, S., McGettigan, J. P., Schnell, M. J., Dietzschold, B.
(2002). Overexpression of the Rabies Virus Glycoprotein Results in Enhancement of Apoptosis and Antiviral Immune Response. J. Virol.
76: 3374-3381
[Abstract]
[Full Text]
-
Pulmanausahakul, R., Faber, M., Morimoto, K., Spitsin, S., Weihe, E., Hooper, D. C., Schnell, M. J., Dietzschold, B.
(2001). Overexpression of Cytochrome c by a Recombinant Rabies Virus Attenuates Pathogenicity and Enhances Antiviral Immunity. J. Virol.
75: 10800-10807
[Abstract]
[Full Text]
-
McGettigan, J. P., Sarma, S., Orenstein, J. M., Pomerantz, R. J., Schnell, M. J.
(2001). Expression and Immunogenicity of Human Immunodeficiency Virus Type 1 Gag Expressed by a Replication-Competent Rhabdovirus-Based Vaccine Vector. J. Virol.
75: 8724-8732
[Abstract]
[Full Text]
-
Prosniak, M., Hooper, D. C., Dietzschold, B., Koprowski, H.
(2001). Effect of rabies virus infection on gene expression in mouse brain. Proc. Natl. Acad. Sci. USA
98: 2758-2763
[Abstract]
[Full Text]
-
UBOL, S., KASISITH, J.
(2000). Reactivation of Nedd-2, a developmentally down-regulated apoptotic gene, in apoptosis induced by a street strain of rabies virus. J Med Microbiol
49: 1043-1046
[Abstract]
[Full Text]